SCHEMBL7884259

SCHEMBL7884259

CCN(CC)Cc1ccc(Oc2cc(Cl)c3cc(C(=O)N=C(N)NC)[nH]c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 2/20 0.36
HRH3 Q9Y5N1 2/20 0.34
PARP1 P09874 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
MDM2 Q00987 1/20 0.33
ACHE P22303 2/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
CHEK2 O96017 2/20 0.32
MAPK1 P28482 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HTR2A P28223 1/20 0.31
SLC6A4 P31645 1/20 0.31
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877544 0.91 SLC6A4 (0.38) RHEBPARP1PARP2MDM2CHEK2
SCHEMBL7881963 0.90 PPARG (0.38) RHEBACHEMEN1KMT2APPARG
SCHEMBL7881488 0.90 HRH3 (0.42) HRH3PARP1PARP2MDM2L3MBTL1
Hydrochloric Acid SCHEMBL7881328 0.90 SLC6A4 (0.37) RHEBPARP1PARP2MDM2CHEK2
SCHEMBL7880747 0.90 DYRK1A (0.34) RHEB
SCHEMBL7879412 0.88 RHEB (0.39) RHEBCHEK2PPARGPPARDPPARA
SCHEMBL7879952 0.88 RHEB (0.35) RHEBHRH3ACHEHDAC8HDAC6
Hydrochloric Acid SCHEMBL7881148 0.87 RHEB (0.39) RHEBCHEK2PPARGPPARDPPARA
SCHEMBL7882284 0.86 LOXL2 (0.32)
SCHEMBL7882132 0.85 KDR (0.32) RHEB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed